Skip to main contentSkip to navigation
Sirius Investors
NeonMind Biosciences Inc.

NeonMind Biosciences Inc.

NMDBF
OTCHealthcare

NMDBF Financial Statements & Analysis

Complete financial statements for NMDBF including income statement, balance sheet, and cash flow statement. Analyze NMDBF's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).

Financial Health Score

Financial Health Score

/100
Unlock score for free

Already registered? Sign in

Income Statement

Revenue
100.0%
Net Income
18.8%
Gross Margin
-100.0%
Operating Margin
-100.0%

Balance Sheet

Current Ratio
-44.3%
Debt to Equity
8.6%
Asset Turnover
100.0%

Cash Flow

Operating Cash Flow
42.3%
Net Cash Flow
11.5%
Free Cash Flow
42.3%
Cash Flow to Debt
34.3%

Income Statement Comparison

Revenue & Net Income

Period Comparison

MetricTTM Q3 '22TTM Q4 '22ChangeImpact
Revenue-16.07K0100.0%
Gross Profit-16.07K0100.0%
Operating Income-1.71M-1.75M2.3%
Net Income-2.51M-2.04M18.8%
EPS-0.58-0.615.0%
EBITDA-1.67M-1.70M2.2%
Gross Margin100.00%0.00%100.0%
Operating Margin10653.35%0.00%100.0%
Net Income Margin15589.84%0.00%100.0%
R&D Expenses418.45K149.02K64.4%

Income Statement Full Table

Free users can view the last 3 periods. Upgrade to see the full history.

Upgrade
MetricTTM Q4 '22TTM Q3 '22TTM Q2 '22TTM Q1 '22TTM Q4 '21
Revenue0-16.07K-12.65K
Gross Profit0-16.07K-13.82K
Operating Income-1.75M-1.71M-4.06M
Net Income-2.04M-2.51M-3.87M
EPS-0.61-0.58-0.92
EBITDA-1.70M-1.67M-4.06M
Gross Margin0.00%100.00%109.26%
Operating Margin0.00%10653.35%32065.78%
Net Income Margin0.00%15589.84%30555.78%
R&D Expenses149.02K418.45K979.24K

Our detailed financial analysis helps investors understand NMDBF's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track NMDBF's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.

Financial Metrics

Want to dive deeper into NMDBF's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.

View Financial Metrics
NeonMind Biosciences Inc. (NMDBF) Financial Statements (2026): Income, Balance Sheet & Cash Flow | Sirius Investors